Chemed Corporation (CHE)
NYSE: CHE · Real-Time Price · USD
447.55
+2.02 (0.45%)
At close: Nov 12, 2025, 4:00 PM EST
447.55
0.00 (0.00%)
After-hours: Nov 12, 2025, 7:00 PM EST
Chemed Market Cap
Chemed has a market cap or net worth of $6.31 billion as of November 12, 2025. Its market cap has decreased by -30.42% in one year.
Market Cap
6.31B
Enterprise Value
6.33B
1-Year Change
-30.42%
Ranking
Category
Stock Price
$447.55
Market Cap Chart
Since December 1, 1998, Chemed's market cap has increased from $321.30M to $6.31B, an increase of 1,865.28%. That is a compound annual growth rate of 11.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2025 | 6.31B | -20.50% |
| Dec 31, 2024 | 7.94B | -9.88% |
| Dec 29, 2023 | 8.81B | 16.04% |
| Dec 30, 2022 | 7.59B | -6.81% |
| Dec 31, 2021 | 8.14B | -4.14% |
| Dec 31, 2020 | 8.50B | 20.82% |
| Dec 31, 2019 | 7.03B | 55.03% |
| Dec 31, 2018 | 4.54B | 16.90% |
| Dec 29, 2017 | 3.88B | 49.09% |
| Dec 30, 2016 | 2.60B | 2.93% |
| Dec 31, 2015 | 2.53B | 40.67% |
| Dec 31, 2014 | 1.80B | 33.04% |
| Dec 31, 2013 | 1.35B | 2.12% |
| Dec 31, 2012 | 1.32B | 29.95% |
| Dec 30, 2011 | 1.02B | -29.66% |
| Dec 31, 2010 | 1.45B | 33.77% |
| Dec 31, 2009 | 1.08B | 21.63% |
| Dec 31, 2008 | 889.70M | -33.46% |
| Dec 31, 2007 | 1.34B | 37.62% |
| Dec 29, 2006 | 971.50M | -24.07% |
| Dec 30, 2005 | 1.28B | 52.89% |
| Dec 31, 2004 | 836.80M | 83.67% |
| Dec 31, 2003 | 455.60M | 31.56% |
| Dec 31, 2002 | 346.30M | 3.90% |
| Dec 31, 2001 | 333.30M | -0.98% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 885.19B |
| Johnson & Johnson | 466.99B |
| AbbVie | 397.96B |
| UnitedHealth Group | 296.62B |
| AstraZeneca | 275.02B |
| Novartis AG | 249.68B |
| Merck & Co. | 225.74B |
| Abbott Laboratories | 220.84B |